| Value | ₹138.0 Cr |
|---|
BSE filing, NSE: LAXMIDENTL. Summary written from the filing by ALFA Finder's alert engine.
Laxmi Dental Ltd: key numbers
- Share price
- ₹177.58
- Market cap
- ₹977.2 Cr
- Revenue (annual)
- ₹277.9 Cr
- Net profit (annual)
- ₹28.98 Cr
- P/E (TTM)
- 31.6×Sector 52.8×
- Promoter holding
- 41.75%-0.05% QoQ
- FII holding
- 6.57%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Laxmi Dental Ltd
All →Laxmi Dental Board Meeting Date
Laxmi Dental scheduled a board meeting for November 3, 2026, to consider unaudited Q1 FY27 financial results. No financial figures are disclosed in this prior intimation.
Laxmi Dental Merger & Restructuring
Laxmi Dental Limited announced the incorporation of Leelaben Foundation, a Section 8 company, in which the company is a member, as previously approved by its board.
Laxmi Dental Business Update
Laxmi Dental's subsidiary received a tariff refund of ₹5.92 Crore from U.S. Customs following a regulatory change regarding excess tariffs collected.
- Value
- ₹5.92 Cr
- From
- U.S. Customs and Border Protection (CBP)
Laxmi Dental Legal & Regulatory
Laxmi Dental Limited's subsidiary, Laxmi Dental Lab USA, INC, received a tariff refund of approximately INR 5.92 Crore from U.S. Customs and Border Protection.
- Value
- ₹5.92 Cr
Laxmi Dental Other Announcement
The filing contains the quarterly shareholding pattern for Laxmi Dental Ltd as of September 30, 2026, submitted in compliance with SEBI Regulation 31(1)(b).
Laxmi Dental Other Announcement
Laxmi Dental submitted the Monitoring Agency Report for the quarter ended September 30, 2026, confirming utilization of IPO proceeds is in line with stated objects.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.